Bio-Rad Laboratories Class B
BIO.B
6 hedge funds and large institutions have $4.58M invested in Bio-Rad Laboratories Class B in 2015 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
20% more funds holding
Funds holding: 5 → 6 (+1)
14% more capital invested
Capital invested by funds: $4.03M → $4.58M (+$552K)
0.03% more ownership
Funds ownership: 0.58% → 0.61% (+0.03%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIM
Spark Investment Management
New York
|
+$193K |
| 2 |
Citigroup
New York
|
+$3.45K |
| 3 |
Barclays
London,
United Kingdom
|
+$1.24K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1.52K |
| 2 |
FNYS
First New York Securities
New York
|
-$1.49K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CL
1
CSS LLC
Chicago,
Illinois
| $3.27M | – | – | – |
|
2
Dimensional Fund Advisors
Austin,
Texas
| $957K | – | – | – |
|
|
SIM
3
Spark Investment Management
New York
| $205K | +$193K | +1,400 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $149K | -$1.52K | -11 | -1% |
|
|
5
Citigroup
New York
| $4K | +$3.45K | +25 | New |
|
|
6
Barclays
London,
United Kingdom
| $1K | +$1.24K | +9 | New |
|
|
FNYS
7
First New York Securities
New York
| – | -$1.49K | -11 | Closed |
|
BIO.B Hedge Fund Activity: Q2 2015 in Review
6 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q2 2015, worth a combined $4.58M — up 14% from $4.03M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new BIO.B positions and 2 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Spark Investment Management, opening a new position worth an estimated $193K. The largest seller was UBS Group, cutting an estimated $1.52K.
- 6 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q2 2015, up from 5 in Q1 2015.
- Funds reported $4.58M of Bio-Rad Laboratories Class B stock for Q2 2015, up 14% quarter-over-quarter.
- 3 funds opened new Bio-Rad Laboratories Class B positions in Q2 2015 and 2 closed out, a net change of +1 holder.
- The largest Bio-Rad Laboratories Class B buyer in Q2 2015 was Spark Investment Management, an estimated $193K added.
- The largest Bio-Rad Laboratories Class B seller in Q2 2015 was UBS Group, an estimated $1.52K sold.
Based on aggregated 13F filings for Q2 2015.